Thursday, November 12, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 4, 2026

DeepHealth Unveils Industry’s Most Comprehensive Portfolio of Native Clinical AI Solutions at ECR 2026

View original at finance.yahoo.com
DeepHealth Unveils Industry’s Most Comprehensive Portfolio of Native Clinical AI Solutions at ECR 2026 RadNet, Inc…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Neuro Suite demonstrated 92% sensitivity in early identification of hippocampal atrophy associated with mild cognitive disorders and Alzheimer's disease

    80% confidence
  • Breast Suite AI-powered risk assessment tool predicts patient's near-term cancer risk with 2x greater accuracy than traditional risk models

    80% confidence
  • DeepHealth's unified platform has fundamentally changed how we serve our patients. From prostate and lung cancer screening to the assessment of neurodegenerative disease, we now have one cohesive, AI-powered ecosystem that gives our radiologists the clinical confidence to detect disease earlier and the workflow efficiency to do it at scale

    80% confidence
  • These solutions transform imaging pathways, enabling healthcare systems to move from reactive treatment to proactive intervention while addressing the realities of diverse European markets, to improve patient outcomes

    80% confidence
  • Thyroid Suite deployment demonstrated ability to reduce scan slot time by up to 30% at RadNet sites

    80% confidence
  • As European nations scale their screening ambitions and confront rising workload pressures, our integrated portfolio is designed to stage shift disease, empower diagnostic excellence and expand patient access, thereby driving precision care

    80% confidence
  • Radiologists accepted AI-based measurements and characterization without correction in greater than 94% of thyroid imaging cases across 240+ RadNet sites

    80% confidence
  • With Gleamer integration, DeepHealth now offers the most comprehensive radiology AI portfolio in the market

    80% confidence
  • DeepHealth's expanded portfolio delivers the industry's most comprehensive portfolio of native clinical AI solutions across all core imaging modalities

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com
DeepHealth Unveils Industry’s Most Comprehensive Portfolio of Native Clinical AI Solutions at ECR 2026 — Source | Via News | Via News